Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 92 (3) , 604-607
- https://doi.org/10.1016/0016-5085(87)90007-2
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Role of endogenous gastric prostanoids in the pathogenesis and therapy of duodenal ulcerGastroenterology, 1986
- Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcersDigestive Diseases and Sciences, 1985
- Prostaglandins in pathophysiology of peptic ulcer diseaseDigestive Diseases and Sciences, 1985
- Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer diseaseGastroenterology, 1985
- Duodenal mucosa synthesis of prostaglandins in duodenal ulcer disease.Gut, 1985
- Protection of the Gastroduodenal Mucosa by ProstaglandinsScandinavian Journal of Gastroenterology, 1985
- Effect of 15(R)-15-Methyl Prostaglandin E2 (Arbaprostil) on the Healing of Duodenal UlcerGastroenterology, 1982
- Effect of Orally Administered 15(R)-15-Methyl Prostaglandin E2and/or an Anticholinergic Drug on Meal-induced Gastric Acid Secretion and Serum Gastrin Level in Patients with Duodenal UlcersScandinavian Journal of Gastroenterology, 1979
- The effect of 15(R)-15-methyl prostaglandin E2 on meal-stimulated gastric acid secretion, serum gastrin, and pancreatic polypeptide in duodenal ulcer patientsDigestive Diseases and Sciences, 1979
- The effect of 15 (R) 15 methyl prostaglandin E2 on gastric acid secretion in duodenal ulcer patientsProstaglandins, 1977